Express News | Agios Pharmaceuticals - to Discontinue Pyrukynd if Hepatic Injury Due to Pyrukynd Is Suspected

Reuters30minutes ago

Express News | Agios Pharmaceuticals - Uspi Sections Updated to Include Liver Injury Information

Reuters32minutes ago

Express News | Agios Pharmaceuticals - FDA Approves Update to Uspi for Pyrukynd for Hemolytic Anemia

Reuters32minutes ago

How to Navigate the Stock and Bond Markets in 2025 -- Journal Report

Dow JonesJan 3 10:00 ET

Agios to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025

GlobeNewswireJan 3 07:00 ET

The Best U.S. Value Stocks by Quant: AGIO, DLX, PPC

Seeking AlphaDec 26, 2024 11:22 ET